Systems Biology-Based Platforms to Accelerate Research of Emerging Infectious Diseases

키워드

참고문헌 (92)

1. Morse SS, "From the National Institute of Allergy and Infectious Diseases, the Fogarty International Center of the National Institutes of Health, and the Rockefeller University. Emerging viruses: the evolution of viruses and viral diseases", J Infect Dis, 162, pp.1~7 (1990)[DOI]
2. Morse SS, "Developing an integrated epidemiologic approach to emerging infectious diseases", Epidemiol Rev, 18, pp.1~3 (1996)[DOI]
3. Woolhouse M, "Human viruses: discovery and emergence", Philos Trans R Soc Lond B Biol Sci, 367, pp.2864~2871 (2012)[DOI]
4. Woolhouse ME, "Population biology of emerging and re-emerging pathogens", Trends Microbiol, 10(10 Suppl), pp.S3~S7 (2002)[DOI]
5. Woolhouse ME, "Host range and emerging and reemerging pathogens", Emerg Infect Dis, 11, pp.1842~1847 (2005)[DOI]
6. Grimm SK, "Vaccine design: emerging concepts and renewed optimism", Curr Opin Biotechnol, 24, pp.1078~1088 (2013)[DOI]
7. Nakaya HI, "Vaccinology in the era of high-throughput biology", Philos Trans R Soc Lond B Biol Sci, 370, pp.20140146~ (2015)[DOI]
8. Koff WC, "Accelerating next-generation vaccine development for global disease prevention", Science, 340, pp.1232910~ (2013)[DOI]
9. Westerhoff HV, "Systems biology: the elements and principles of life", FEBS Lett, 583, pp.3882~3890 (2009)[DOI]
10. Nakaya HI, "Systems vaccinology: learning to compute the behavior of vaccine induced immunity", Wiley Interdiscip Rev Syst Biol Med, 4, pp.193~205 (2012)[DOI]
11. Li S, "Systems biological approaches to measure and understand vaccine immunity in humans", Semin Immunol, 25, pp.209~218 (2013)[DOI]
12. Pulendran B, "Systems vaccinology", Immunity, 33, pp.516~529 (2010)[DOI]
13. Pulendran B, "Immunity to viruses: learning from successful human vaccines", Immunol Rev, 255, pp.243~255 (2013)[DOI]
14. Almeida SL, "Trending now: re-emerging infectious disease update", J Emerg Nurs, 41, pp.104~108 (2015)[DOI]
15. Howard CR, "Emerging virus diseases: can we ever expect the unexpected?", Emerg Microbes Infect, 1, pp.e46~ (2012)[DOI]
16. Dash AP, "Emerging and reemerging arboviral diseases in Southeast Asia", J Vector Borne Dis, 50, pp.77~84 (2013)
17. Morse SS, "Factors in the emergence of infectious diseases", Emerg Infect Dis, 1, pp.7~15 (1995)[DOI]
18. Lauring AS, "The role of mutational robustness in RNA virus evolution", Nat Rev Microbiol, 11, pp.327~336 (2013)[DOI]
19. Webster RG, "Evolution and ecology of influenza A viruses", Microbiol Rev, 56, pp.152~179 (1992)
20. Yoon SW, "Evolution and ecology of influenza A viruses", Curr Top Microbiol Immunol, 385, pp.359~375 (2014)
21. Short KR, "One health, multiple challenges: the inter-species transmission of influenza A virus", One Health, 1, pp.1~13 (2015)[DOI]
22. Wilson ME, "Travel and the emergence of infectious diseases", Emerg Infect Dis, 1, pp.39~46 (1995)
23. Wilson ME, "The traveller and emerging infections: sentinel, courier, transmitter", J Appl Microbiol, 94(Suppl), pp.1S~11S (2003)
24. Hwang GM, "A model-based tool to predict the propagation of infectious disease via airports", Travel Med Infect Dis, 10, pp.32~42 (2012)[DOI]
25. Cho SY, "MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study", Lancet, 388, pp.994~1001 (2016)[DOI]
26. Park WB, "Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea", Emerg Infect Dis, 21, pp.2186~2189 (2015)[DOI]
27. Beugnet F, "Impact of climate change in the epidemiology of vector-borne diseases in domestic carnivores", Comp Immunol Microbiol Infect Dis, 36, pp.559~566 (2013)[DOI]
28. Medlock JM, "An entomological review of invasive mosquitoes in Europe", Bull Entomol Res, 105, pp.637~663 (2015)[DOI]
29. Murray NE, "Epidemiology of dengue: past, present and future prospects", Clin Epidemiol, 5, pp.299~309 (2013)
30. Stone BL, "Brave new worlds: the expanding universe of Lyme disease", Vector Borne Zoonotic Dis, 17, pp.619~629 (2017)[DOI]
31. Ostfeld RS, "Climate change and Ixodes tick-borne diseases of humans", Philos Trans R Soc Lond B Biol Sci, 370, pp.20140051~ (2015)[DOI]
32. Choi YK, "Swine influenza viruses: an Asian perspective", Curr Top Microbiol Immunol, 370, pp.147~172 (2013)
33. Chen R, "Avian influenza virus exhibits rapid evolutionary dynamics", Mol Biol Evol, 23, pp.2336~2341 (2006)[DOI]
34. Su S, "Epidemiology, evolution, and pathogenesis of H7N9 Influenza viruses in five epidemic waves since 2013 in China", Trends Microbiol, 25, pp.713~728 (2017)[DOI]
35. Wang X, "Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series", Lancet Infect Dis, 17, pp.822~832 (2017)[DOI]
36. Liu Q, "Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis", Lancet Infect Dis, 14, pp.763~772 (2014)[DOI]
37. Zhan J, "Current status of severe fever with thrombocytopenia syndrome in China", Virol Sin, 32, pp.51~62 (2017)[DOI]
38. Yun SM, "Severe fever with thrombocytopenia syndrome virus in ticks collected from humans, South Korea, 2013", Emerg Infect Dis, 20, pp.1358~1361 (2014)[DOI]
39. Takahashi T, "The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan", J Infect Dis, 209, pp.816~827 (2014)[DOI]
40. 신상용, "Bone Marrow Suppression and Hemophagocytic Histiocytes Are Common Findings in Korean Severe Fever with Thrombocytopenia Syndrome Patients", Yonsei Medical Journal, 57(5), pp.1286~1289 (2016), 연세대학교의과대학[DOI]
41. 오원섭, "Effect of Early Plasma Exchange on Survival in Patients with Severe Fever with Thrombocytopenia Syndrome: A Multicenter Study", Yonsei Medical Journal, 58(4), pp.867~871 (2017), 연세대학교의과대학[DOI]
42. Gai ZT, "Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients", J Infect Dis, 206, pp.1095~1102 (2012)[DOI]
43. Kim WY, "Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea", Clin Infect Dis, 60, pp.1681~1683 (2015)[DOI]
44. Bao CJ, "A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission", Clin Infect Dis, 53, pp.1208~1214 (2011)[DOI]
45. Tang X, "Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood", J Infect Dis, 207, pp.736~739 (2013)[DOI]
46. Zaki AM, "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia", N Engl J Med, 367, pp.1814~1820 (2012)[DOI]
47. Azhar EI, "The middle east respiratory syndrome coronavirus-a continuing risk to global health security", Adv Exp Med Biol, 972, pp.49~60 (2017)
48. de Wit E, "SARS and MERS: recent insights into emerging coronaviruses", Nat Rev Microbiol, 14, pp.523~534 (2016)[DOI]
49. Memish ZA, "Middle East respiratory syndrome coronavirus in bats, Saudi Arabia", Emerg Infect Dis, 19, pp.1819~1823 (2013)
50. Gubler DJ, "Dengue, urbanization and globalization: the unholy trinity of the 21(st) century", Trop Med Health, 39(4 Suppl), pp.3~11 (2011)[DOI]
51. Diamond MS, "Molecular insight into dengue virus pathogenesis and its implications for disease control", Cell, 162, pp.488~492 (2015)[DOI]
52. Halstead SB, "Dengue", Lancet, 370, pp.1644~1652 (2007)[DOI]
53. Park JH, "Dengue fever in South Korea, 2006-2010", Emerg Infect Dis, 18, pp.1525~1527 (2012)[DOI]
54. Miki S, "A comparative study of the trends of imported Dengue cases in Korea and Japan 2011-2015", J Clin Med Res, 9, pp.650~653 (2017)[DOI]
55. Musso D, "Zika virus", Clin Microbiol Rev, 29, pp.487~524 (2016)[DOI]
56. Mlakar J, "Zika virus associated with microcephaly", N Engl J Med, 374, pp.951~958 (2016)[DOI]
57. 임슬기, "An Update on Zika Virus in Asia", Infection and Chemotherapy, 49(2), pp.91~100 (2017), 대한감염학회
58. 장희창, "First Imported Case of Zika Virus Infection into Korea", Journal of Korean Medical Science, 31(7), pp.1173~1177 (2016), 대한의학회
59. Aderem A, "A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm", MBio, 2, pp.e00325~10 (2011)
60. Mei B, "Global gene expression changes in human peripheral blood after H7N9 infection", Gene, 551, pp.255~260 (2014)[DOI]
61. Wang Y, "RNA-seq analysis revealed novel genes and signaling pathway associated with disease resistance to avian influenza virus infection in chickens", Poult Sci, 93, pp.485~493 (2014)[DOI]
62. Ertl R, "Transcriptional profiling of the host cell response to feline immunodeficiency virus infection", Virol J, 11, pp.52~ (2014)[DOI]
63. Jones M, "RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation", PLoS Pathog, 10, pp.e1003896~ (2014)[DOI]
64. Rossetto CC, "Regulation of viral and cellular gene expression by Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA", J Virol, 87, pp.5540~5553 (2013)[DOI]
65. Juranic Lisnic V, "Dual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virushost cell interface", PLoS Pathog, 9, pp.e1003611~ (2013)[DOI]
66. Park SJ, "Dynamic changes in host gene expression associated with H5N8 avian influenza virus infection in mice", Sci Rep, 5, pp.16512~ (2015)[DOI]
67. Nowakowski TJ, "Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells", Cell Stem Cell, 18, pp.591~596 (2016)[DOI]
68. Onorati M, "Zika virus disrupts Phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial glia", Cell Rep, 16, pp.2576~2592 (2016)[DOI]
69. Ahmed N, "How to design effective vaccines: lessons from an old success story", Expert Rev Vaccines, 8, pp.543~546 (2009)[DOI]
70. Querec TD, "Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans", Nat Immunol, 10, pp.116~125 (2009)
71. Nakaya HI, "Systems biology of vaccination for seasonal influenza in humans", Nat Immunol, 12, pp.786~795 (2011)[DOI]
72. Oh JZ, "TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination", Immunity, 41, pp.478~492 (2014)[DOI]
73. Ravindran R, "Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation", Science, 343, pp.313~317 (2014)[DOI]
74. Nakaya HI, "Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures", Immunity, 43, pp.1186~1198 (2015)[DOI]
75. Nakaya HI, "Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood", Proc Natl Acad Sci U S A, 113, pp.1853~1858 (2016)[DOI]
76. Kazmin D, "Systems analysis of protective immune responses to RTS,S malaria vaccination in humans", Proc Natl Acad Sci U S A, 114, pp.2425~2430 (2017)[DOI]
77. Li S, "Metabolic phenotypes of response to vaccination in humans", Cell, 169, pp.862~877 (2017)[DOI]
78. Hoek KL, "A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination", PLoS One, 10, pp.e0118528~ (2015)[DOI]
79. Mizukami T, "System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test", PLoS One, 9, pp.e101835~ (2014)[DOI]
80. Bucasas KL, "Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans", J Infect Dis, 203, pp.921~929 (2011)[DOI]
81. Pulendran B, "Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology", Nat Rev Immunol, 9, pp.741~747 (2009)[DOI]
82. Gaucher D, "Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses", J Exp Med, 205, pp.3119~3131 (2008)[DOI]
83. O'Hagan DT, "Towards an evidence based approach for the development of adjuvanted vaccines", Curr Opin Immunol, 47, pp.93~102 (2017)[DOI]
84. Vesikari T, "Oil-in-water emulsion adjuvant with influenza vaccine in young children", N Engl J Med, 365, pp.1406~1416 (2011)[DOI]
85. Vesikari T, "Safety and immunogenicity of an <TEX>$MF59(^{(R)})$<", TEX>-adjuvanted A, Vaccine, pp.2012, 30[DOI]
86. Six A, "Systems biology in vaccine design", Microb Biotechnol, 5, pp.295~304 (2012)[DOI]
87. Henn AD, "High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature", Sci Rep, 3, pp.2327~ (2013)[DOI]
88. Chaussabel D, "Assessing the human immune system through blood transcriptomics", BMC Biol, 8, pp.84~ (2010)[DOI]
89. Rappuoli R, "Reverse vaccinology", Curr Opin Microbiol, 3, pp.445~450 (2000)[DOI]
90. Rappuoli R, "Vaccine discovery and translation of new vaccine technology", Lancet, 378, pp.360~368 (2011)[DOI]
91. Korber B, "Immunoinformatics comes of age", PLoS Comput Biol, 2, pp.e71~ (2006)[DOI]
92. Sievers SA, "Antibody engineering for increased potency, breadth and half-life", Curr Opin HIV AIDS, 10, pp.151~159 (2015)[DOI]

관련 논문AI추천